Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation

Eftihia Cocolakis1, Meiou Dai1, Loren Drevet1

  • 1Hormones and Cancer Research Unit, Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Quebec H3A 1A1, Canada.

Insights

Transforming growth factor-beta (TGFbeta)/Smad signaling antagonizes prolactin/JAK/STAT pathways in mammary glands. Activated Smads block STAT5 co-activator binding, inhibiting mammary gland growth and differentiation.

Area of Science:

  • Cellular signaling pathways
  • Mammary gland biology
  • Molecular mechanisms of gene regulation

Background:

  • The transforming growth factor-beta (TGFbeta)/Smad and prolactin/JAK/STAT pathways are crucial for mammary epithelial tissue development and function.
  • Opposing roles of these pathways in mammary gland development are known, but their interaction remains unclear.

Purpose of the Study:

  • To elucidate the regulatory cross-talk between Smad and STAT signaling pathways in mammary epithelial cells.
  • To investigate how TGFbeta signaling influences prolactin-mediated JAK/STAT signaling.
  • To understand the molecular basis of antagonism between these pathways.

Main Methods:

  • Investigated the effects of TGFbeta and activin on JAK/STAT signaling in mammary epithelial cells.
  • Analyzed the impact of Smad activation on STAT5 transactivation and target gene expression (beta-casein, cyclin D1).
  • Examined the interaction between activated Smads, STAT5, and CREB-binding protein.

Main Results:

  • TGFbeta-induced Smad signaling was found to antagonize prolactin-mediated JAK/STAT signaling.
  • Activin and TGFbeta efficiently blocked STAT5 signaling and beta-casein expression.
  • Activated Smads directly inhibited STAT5 transactivation by blocking its association with CREB-binding protein.
  • This antagonism blocked mammary gland growth, differentiation, and lactation.

Conclusions:

  • A novel cross-talk mechanism exists where Smad signaling inhibits JAK/STAT signaling in mammary epithelial cells.
  • Smad activation blocks STAT5-mediated transcription of key genes like beta-casein and cyclin D1.
  • This pathway interaction is critical for regulating mammary gland development, differentiation, and lactation.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...